RNA, U6 small nuclear 1216, pseudogene (RNU6-1216P)

RNA, U6 small nuclear 1216, pseudogene (RNU6-1216P) is annotated as a pseudogene derived from the U6 small nuclear RNA family, located on human chromosome 2 (chr2:69,182,877-69,182,983, forward strand)[1][3][5][7]. Pseudogenes are gene sequences that resemble functional genes but have lost their protein-coding ability or regulatory potential due to accumulated mutations[2][4]. RNU6-1216P does not encode a functional protein or RNA and is not documented as being transcribed at physiologically meaningful levels. Unlike functional U6 small nuclear RNAs, which participate in spliceosome assembly and pre-mRNA splicing, pseudogenes such as RNU6-1216P have no known direct and specific regulatory or functional role. Some pseudogenes may function as regulatory RNAs by acting as antisense RNAs, small interfering RNAs (siRNAs), or competing endogenous RNAs, influencing gene expression indirectly, especially for their parental genes[2][4]. However, there is currently no evidence supporting such a role for RNU6-1216P. RNU6-1216P is not considered a therapeutic target, receptor, enzyme, transporter, or druggable entity. No clinical biomarkers, disease associations, safety concerns, or drug interactions are established for this pseudogene. In summary, RNU6-1216P is a U6 small nuclear RNA pseudogene, without known biological function, disease role, or value as a therapeutic target[1][3][5][7].

Other names

ENSG00000199460106480098